Glenmark Rufinamide Tablets Recalled for Manufacturing Process Deviations
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
- Product
- RUFINAMIDE — RUFINAMIDE (RUFINAMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide